Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/40939
Type: Artigo de Periódico
Title: Shortened derivatives from native antimicrobial peptide LyeTx I: in vitro and in vivo biological activity assessment
Authors: Leonardo Lima Fuscaldi
Joaquim Teixeira de Avelar Júnior
Daniel Moreira dos Santos
Daiane Boff
Vívian Louise Soares de Oliveira
Karla Aparecida Guimarães Gusmão Gomes
Rosana de Carvalho Cruz
Patrícia Luciana de Oliveira
Paula Prazeres Magalhães
Patricia Silva Cisalpino
Luiz de Macêdo Farias
Elaine Maria de Souza-Fagundes
Johannes Delp
Marcel Leist
Jarbas Magalhães Resende
Flávio Almeida Amaral
Adriano Monteiro de Castro Pimenta
Simone Odília Antunes Fernandes
Valbert Nascimento Cardoso
Maria Elena de Lima
Abstract: In the continuing search for novel antibiotics, antimicrobial peptides are promising molecules, due to different mechanisms of action compared to classic antibiotics and to their selectivity for interaction with microorganism cells rather than with mammalian cells. Previously, our research group has isolated the antimicrobial peptide LyeTx I from the venom of the spider Lycosa erythrognatha. Here, we proposed to synthesize three novel shortened derivatives from LyeTx I (LyeTx I mn; LyeTx I mnΔK; LyeTx I mnΔKAc) and to evaluate their toxicity and biological activity as potential antimicrobial agents. Peptides were synthetized by Fmoc strategy and circular dichroism analysis was performed, showing that the three novel shortened derivatives may present membranolytic activity, like the original LyeTx I, once they folded as an alpha helix in 2.2.2-trifluorethanol and sodium dodecyl sulfate. In vitro assays revealed that the shortened derivative LyeTx I mnΔK presents the best score between antimicrobial (↓ MIC) and hemolytic (↑ EC50) activities among the synthetized shortened derivatives, and LUHMES cell-based NeuriTox test showed that it is less neurotoxic than the original LyeTx I (EC50 [LyeTx I mnΔK] ⋙ EC50 [LyeTx I]). In vivo data, obtained in a mouse model of septic arthritis induced by Staphylococcus aureus, showed that LyeTx I mnΔK is able to reduce infection, as demonstrated by bacterial recovery assay (∼10-fold reduction) and scintigraphic imaging (less technetium-99m labeled-Ceftizoxime uptake by infectious site). Infection reduction led to inflammatory process and pain decreases, as shown by immune cells recruitment reduction and threshold nociception increment, when compared to positive control group. Therefore, among the three shortened peptide derivatives, LyeTx I mnΔK is the best candidate as antimicrobial agent, due to its smaller amino acid sequence and toxicity, and its greater biological activity.
Subject: Processo inflamatório
Peptídeo antimicrobiano
language: eng
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: FAR - DEPARTAMENTO DE ALIMENTOS
FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS
ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA
ICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICA
ICX - DEPARTAMENTO DE QUÍMICA
Rights: Acesso Aberto
metadata.dc.identifier.doi: 10.1177/1535370220966963
URI: http://hdl.handle.net/1843/40939
Issue Date: Feb-2021
metadata.dc.url.externa: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885047/
metadata.dc.relation.ispartof: Experimental Biology and Medicine
Appears in Collections:Artigo de Periódico



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.